China revising GMPs

China is expected to enact a new version of its good manufacturing practices to ensure the quality and safety of national medicines. Future production will need to follow the revised GMP standards, says China Financial Daily.

The State Food and Drug Administration says it will focus on the new standards, especially for essential medicines--those required for basic healthcare needs and that are available to the public at all times and in adequate amounts. These drugs are included in a list published for the first time and expected to be updated annually, according to China Knowledge.

To meet the new standards, some facilities and manufacturing processes may require re-inspection.

- here's the Financial Daily report
- read the China Knowledge item

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)